EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
Carl Zeiss Meditec generated revenue of around €947.2m in the first six months of fiscal year 2023/24 (prior year: €974.5m), corresponding to a slight decrease in revenue of -2.8% (adjusted for currency effects: -0.7%).
- Carl Zeiss Meditec generated revenue of around €947.2m in the first six months of fiscal year 2023/24 (prior year: €974.5m), corresponding to a slight decrease in revenue of -2.8% (adjusted for currency effects: -0.7%).
- The Microsurgery strategic business unit generated revenue of €246.5m (prior year: €231.9m), corresponding to growth of 6.3% (adjusted for currency effects: 9.1%).
- Revenue in the EMEA [1] region increased by +17.1% (adjusted for currency effects: +20.7%), to €289.4m (prior year: €247.2m).
- Revenue in the Americas region decreased significantly by -20.0% (adjusted for currency effects: -17.9%) from €270.7m to €216.6m.